JACLYN DOMBROSKI: Open Payments
NPI 1407131253 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,139 in 108 payments from 17 companies in 2025. Trend: 2023 $2,358 · 2024 $2,495 · 2025 $2,139
Food & beverage: $2,139
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 28 | $492 |
| AstraZeneca Pharmaceuticals LP | 13 | $296 |
| Lilly USA, LLC | 11 | $237 |
| SHIELD THERAPEUTICS INC | 13 | $234 |
| Exact Sciences Corporation | 7 | $153 |
| KYOWA KIRIN, INC. | 5 | $128 |
| TOLMAR, INC. | 5 | $126 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| ABBVIE INC. | 4 | $79 |
| Phathom Pharmaceuticals, Inc. | 8 | $79 |
Products named: Rybelsus, ACCRUFER, Cologuard Collection Kit, MOUNJARO, FARXIGA, CRYSVITA, Ozempic, JATENZO.
Industry payments across NY — which companies pay providers there.
